Total (n = 32)

Group H (n = 16)

Group L (n = 16)

p value (H vs L)

Physical findings

SBP (mmHg)

137 ± 11

137 ± 12

136 ± 11

0.712

DBP (mmHg)

87 ± 9

86 ± 10

87 ± 9

0.728

BMI (kg/m2)

22.7 [20.0 - 24.7]

24.2 ± 4.6

21.9 ± 3.2

0.110

Laboratory data

HbA1c (%)

6.1 ± 1.0

6.2 ± 1.1

6.1 ± 1.0

0.882

Serum Alb (g/dL)

4.4 ± 0.4

4.4 [4.1 - 4.6]

4.4 ± 0.5

0.495

Serum Cr (mg/dL)

1.28 [1.12 - 1.58]

1.57 [1.41 - 1.76]

1.09 ± 0.13

Serum uric acid (mg/dL)

5.4 ± 1.3

5.7 ± 1.5

5.2 ± 1.0

0.304

Serum potassium (mmol/L)

4.8 ± 0.5

4.8 [4.6 - 5.1]

4.7 ± 0.5

0.335

Serum phosphorus (mg/dL)

2.2 ± 0.5

2.3 ± 0.3

2.2 ± 0.6

0.377

Triglyceride (mg/dL)

116 [94 - 165]

128 [107 - 165]

102 [82 - 169]

0.200

HDL cholesterol (mg/dL)

59 ± 12

58 ± 12

59 ± 13

0.758

LDL cholesterol (mg/dL)

117 ± 29

117 ± 29

116 ± 31

0.930

Medication

Mycophenolatemofetil

32 (100)

16 (100)

16 (100)

Tacrolimus

32 (100)

16 (100)

16 (100)

Cyclosporine

0 (0)

0 (0)

0 (0)

Everolimus

0 (0)

0 (0)

0 (0)

Steroid

32 (100)

16 (100)

16 (100)

Antihypertensive agent

17 (53)

8 (50)

9 (56)

0.723

Diabetes agent

11 (34)

6 (38)

5 (31)

0.710

Dyslipidemia agent

0 (0)

0 (0)

0 (0)

Hyperuricemia agent

1 (3)

1 (6)

0 (0)

0.500